// App-Quantinova.ai

1424 : Presence of Minimal Residual Disease by Flow Cytometry After Induction Chemotherapy Is Less Predictive of Overall and Progression-Free Survival Compared to Conventional Prognostic Factors Including Cytogenetic Risk and Age

Researchers

Presenter

  • Elena Liew

Principal Investigators

  • Jennifer K. Grossman

  • Douglas A. Stewart

  • Joanne Luider

  • Iwona Auer

  • Adnan Mansoor

  • Michelle Geddes

Medical Centers

  • Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada

  • University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada

  • Hematology and Transfusion Medicine, Calgary Laboratory services, University of Calgary, Calgary, AB, Canada

  • Department of Hematology and Hematologic Malignancies, University of Calgary, Calgary,, AB, Canada

  • Department of Surgery, University of Calgary, Calgary, AB, Canada

  • Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

  • Calgary Laboratory Services, Calgary, Alberta, Canada

  • Medicine and Oncology, University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Acute promyelocytic leukemia

  • Acute myelocytic leukemia

  • Mental retardation, autosomal dominant 18

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved